Emerging Microbes & Infections

SCIE

國(guó)際簡(jiǎn)稱：EMERG MICROBES INFEC 參考譯名：新興微生物和感染

主要研究方向：IMMUNOLOGY-MICROBIOLOGY 非預(yù)警期刊審稿周期： 20 Weeks

《新興微生物和感染》(Emerging Microbes & Infections)是一本由Springer Nature出版的以IMMUNOLOGY-MICROBIOLOGY為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽(yù)，影響因子不斷增加，發(fā)行量也同樣高。

2區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
227 年發(fā)文量
8.4 IF影響因子
開(kāi)放 是否OA
31 H-index
2012 創(chuàng)刊年份
1 issue/year 出版周期
English 出版語(yǔ)言

Emerging Microbes & Infections (EMI) is a new open access, fully peer-reviewed international journal. The purpose of EMI is to provide a forum to publish a wide range of scientific reports related to emerging infectious diseases, especially with new information from developing countries where such diseases are constantly arising and being discovered regularly. It will report discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens) including their previously unknown phenotypic or genotypic characteristics, as well as cutting edge information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.

[ 查看全部 ]

投稿咨詢加急咨詢

Emerging Microbes & Infections期刊信息

ISSN：2222-1751
出版語(yǔ)言：English
是否OA：開(kāi)放
E-ISSN：2222-1751
出版地區(qū)：ENGLAND
是否預(yù)警：否
出版商：Springer Nature
出版周期：1 issue/year
創(chuàng)刊時(shí)間：2012
開(kāi)源占比：0.9586
Gold OA文章占比：95.91%
OA被引用占比：0.9983...
出版國(guó)人文章占比：0.33
出版撤稿占比：0
研究類文章占比：95.59%

Emerging Microbes & Infections CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

26.2

2.316

1.653

學(xué)科類別	分區(qū)	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Drug Discovery	Q1	3 / 157	98%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Parasitology	Q1	2 / 79	98%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Infectious Diseases	Q1	9 / 344	97%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Microbiology	Q1	6 / 182	96%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Epidemiology	Q1	6 / 148	96%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Virology	Q1	4 / 80	95%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Immunology	Q1	13 / 236	94%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Emerging Microbes & Infections中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	2區(qū)	INFECTIOUS DISEASES 傳染病學(xué) IMMUNOLOGY 免疫學(xué) MICROBIOLOGY 微生物學(xué)	1區(qū) 2區(qū) 2區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	IMMUNOLOGY 免疫學(xué) INFECTIOUS DISEASES 傳染病學(xué) MICROBIOLOGY 微生物學(xué)	2區(qū) 2區(qū) 2區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	2區(qū)	INFECTIOUS DISEASES 傳染病學(xué) IMMUNOLOGY 免疫學(xué) MICROBIOLOGY 微生物學(xué)	1區(qū) 2區(qū) 2區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	IMMUNOLOGY 免疫學(xué) INFECTIOUS DISEASES 傳染病學(xué) MICROBIOLOGY 微生物學(xué)	2區(qū) 2區(qū) 2區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	2區(qū)	INFECTIOUS DISEASES 傳染病學(xué) IMMUNOLOGY 免疫學(xué) MICROBIOLOGY 微生物學(xué)	1區(qū) 2區(qū) 2區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	IMMUNOLOGY 免疫學(xué) MICROBIOLOGY 微生物學(xué)	2區(qū) 2區(qū)

Emerging Microbes & Infections JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：IMMUNOLOGY	SCIE	Q1	16 / 181	91.4%
學(xué)科：INFECTIOUS DISEASES	SCIE	Q1	8 / 132	94.3%
學(xué)科：MICROBIOLOGY	SCIE	Q1	14 / 161	91.6%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：IMMUNOLOGY	SCIE	Q1	7 / 181	96.41%
學(xué)科：INFECTIOUS DISEASES	SCIE	Q1	5 / 132	96.59%
學(xué)科：MICROBIOLOGY	SCIE	Q1	8 / 161	95.34%

Emerging Microbes & Infections歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Emerging Microbes & Infections中國(guó)學(xué)者發(fā)文選摘

1、Epidemiological characteristics and molecular features of carbapenem-resistant Enterobacter strains in China: a multicenter genomic study
Author: Zhu, Zhichen; Xie, Xiaofang; Yu, Hua; Jia, Wei; Shan, Bin; Huang, Bin; Qu, Fen; Niu, Siqiang; Lv, Jinnan; Gao, Qizhao; Qian, Feinan; Tian, Xiangxiang; Zhai, Yaxuan; Wen, Yicheng; Yang, Chengcheng; Zhu, Jie; Tang, Yiwei; Chen, Liang; Du, Hong

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2148562
2、Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
Author: Zhu, Liguo; Mao, Naiying; Yi, Changhua; Simayi, Aidibai; Feng, Jialu; Feng, Yi; He, Min; Ding, Songning; Wang, Yin; Wang, Yan; Wei, Mingwei; Hong, Jie; Li, Chuchu; Tian, Hua; Zhou, Lu; Peng, Jiefu; Zhang, Shihan; Song, Ci; Jin, Hui; Zhu, Fengcai; Xu, Wenbo; Zhao, Jun; Bao, Changjun

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2146535
3、Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017-2020
Author: Zhou, Ziqi; Ali, Abraham; Walelign, Elias; Demissie, Getnet F.; El Masry, Ihab; Abayneh, Takele; Getachew, Belayneh; Krishnan, Pavithra; Ng, Daisy Y. M.; Gardner, Emma; Makonnen, Yilma; Miguel, Eve; Chevalier, Veronique; Chu, Daniel K.; So, Ray T. Y.; Von Dobschuetz, Sophie; Mamo, Gezahegne; Poon, Leo L. M.; Peiris, Malik

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2164218
4、Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
Author: Zhong, Guohua; Zhuang, Chunlan; Hu, Xiaowen; Chen, Qi; Bi, Zhaofeng; Jia, Xinhua; Peng, Siying; Li, Yufei; Huang, Yue; Zhang, Qiufen; Hong, Ying; Qiao, Youlin; Su, Yingying; Pan, Huirong; Wu, Ting; Wei, Lihui; Huang, Shoujie; Zhang, Jun; Xia, Ningshao

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2185456
5、Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
Author: Zheng, Xubin; Gui, Xuwei; Yao, Lan; Ma, Jun; He, Yifan; Lou, Hai; Gu, Jin; Ying, Ruoyan; Chen, Liping; Sun, Qin; Liu, Yidian; Ho, Chih-Ming; Lee, Bai-Yu; Clemens, Daniel L.; Horwitz, Marcus A.; Ding, Xianting; Hao, Xiaohui; Yang, Hua; Sha, Wei

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2187247
6、Rational development of multicomponent mRNA vaccine candidates against mpox
Author: Zhang, Rong-Rong; Wang, Zheng-Jian; Zhu, Yi-Long; Tang, Wei; Zhou, Chao; Zhao, Suo-Qun; Wu, Mei; Ming, Tao; Deng, Yong-Qiang; Chen, Qi; Jin, Ning-Yi; Ye, Qing; Li, Xiao; Qin, Cheng-Feng

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2192815
7、Integrated analysis reveals important differences in the gut and oropharyngeal microbiota between children with mild and severe hand, foot, and mouth disease
Author: Zhang, Nan; Mou, Danlei; Li, Tongzeng; Chen, Zhiyun; Ma, Chunhua; Liang, Lianchun; He, Qiushui

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2192819
8、Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles
Author: Zhang, Nailou; Tan, Zhongyuan; Wei, Jinbo; Zhang, Sai; Liu, Yan; Miao, Yuanjiu; Ding, Qingwen; Yi, Wenfu; Gan, Min; Li, Chunjie; Liu, Bin; Wang, Hanzhong; Zheng, Zhenhua

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2174777